CMV Connections: Paul-Bunnell Negative Mononucleosis and ‘Changelings’

Mononuclesosis is an EBV infection that can be diagnosed with the heterophil antibody test developed by Paul and Bunnell. The test is based on the agglutination of sheep erythrocytes with the blood of EBV infected patients. P-B heterophil serology is Continue reading CMV Connections: Paul-Bunnell Negative Mononucleosis and ‘Changelings’

Brincidofovir – Another Drug Fails in Phase 3

It is sad to see a pivotal trial fail, and you have to wonder why we recently had several such late-stage ‘mishaps’. Take Tetraphase’s eravacycline which failed in a Phase 3 cUTI trial. We have analyzed this drug’s failure in earlier Continue reading Brincidofovir – Another Drug Fails in Phase 3

CMV Hyperimmune Globulin Data Inconclusive but New Drug Shows Promise

Treating CMV was never easy making prophylaxis the preferred approach for HSCT patients. Since the late 80ies, trials using hyperimmune globulin have come up with mixed results. While treatment was usually safe, efficacy was a lot much harder to prove.  More specific Continue reading CMV Hyperimmune Globulin Data Inconclusive but New Drug Shows Promise